Quantitative chest CT for subtyping chronic lung allograft dysfunction and its association with survival

被引:18
作者
Horie, Miho [1 ,2 ]
Salazar, Pascal [3 ]
Saito, Tomohito [4 ,5 ,6 ]
Binnie, Matthew [5 ]
Brock, Kristy [7 ]
Yasufuku, Kazuhiro [4 ,5 ]
Azad, Sassan [4 ]
Keshavjee, Shaf [2 ,5 ,6 ]
Martinu, Tereza [5 ]
Paul, Narinder [1 ,2 ]
机构
[1] Univ Toronto, Univ Hlth Network, Joint Dept Med Imaging, Toronto, ON, Canada
[2] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada
[3] Vital Images, Minnetonka, MN USA
[4] Univ Toronto, Univ Hlth Network, Toronto Gen Res Inst, Latner Thorac Surg Res Labs, Toronto, ON, Canada
[5] Univ Toronto, Univ Hlth Network, Toronto Lung Transplant Program, Toronto, ON, Canada
[6] Kansai Med Univ, Dept Thorac Surg, Hirakata, Osaka, Japan
[7] Univ Texas MD Anderson Canc Ctr, Dept Imaging Phys, Houston, TX 77030 USA
关键词
bronchiolitis obliterans syndrome; chronic lung allograft dysfunction; computed tomography; restrictive allograft syndrome; BRONCHIOLITIS OBLITERANS SYNDROME; IDIOPATHIC PULMONARY-FIBROSIS; TRANSPLANT RECIPIENTS; COMPUTED-TOMOGRAPHY; RISK; PROGRESSION; PHENOTYPE; ONSET;
D O I
10.1111/ctr.13233
中图分类号
R61 [外科手术学];
学科分类号
摘要
Chronic lung allograft dysfunction (CLAD) is a major cause of mortality in lung transplant recipients. CLAD can be sub-divided into at least 2 subtypes with distinct mortality risk characteristics: restrictive allograft syndrome (RAS), which demonstrates increased overall computed tomography (CT) lung density in contrast with bronchiolitis obliterans syndrome (BOS), which demonstrates reduced overall CT lung density. This study aimed to evaluate a reader-independent quantitative density metric (QDM) derived from CT histograms to associate with CLAD survival. A retrospective study evaluated CT scans corresponding to CLAD onset using pulmonary function tests in 74 patients (23 RAS, 51 BOS). Two different QDM values (QDM1 and QDM2) were calculated using CT lung density histograms. Calculation of QDM1 includes the extreme edges of the histogram. Calculation of QDM2 includes the central region of the histogram. Kaplan-Meier analysis and Cox regression analysis were used for CLAD prognosis. Higher QDM values were significantly associated with decreased survival. The hazard ratio for death was 3.2 times higher at the 75th percentile compared to the 25th percentile using QDM1 in a univariate model. QDM may associate with CLAD patient prognosis.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Restrictive allograft syndrome (RAS): A novel form of chronic lung allograft dysfunction
    Sato, Masaaki
    Waddell, Thomas K.
    Wagnetz, Ute
    Roberts, Heidi C.
    Hwang, David M.
    Haroon, Ayesha
    Wagnetz, Dirk
    Chaparro, Cecilia
    Singer, Lianne G.
    Hutcheon, Michael. A.
    Keshavjee, Shaf
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (07) : 735 - 742
  • [22] Survival Determinants in Lung Transplant Patients With Chronic Allograft Dysfunction
    Verleden, Geert M.
    Vos, Robin
    Verleden, Stijn E.
    De Wever, Walter
    De Vleeschauwer, Stephanie I.
    Willems-Widyastuti, Anna
    Scheers, Hans
    Dupont, Lieven J.
    Van Raemdonck, Dirk E.
    Vanaudenaerde, Bart M.
    TRANSPLANTATION, 2011, 92 (06) : 703 - 708
  • [23] Chronic lung allograft dysfunction
    Sato, Masaaki
    CURRENT PULMONOLOGY REPORTS, 2014, 3 (03) : 71 - 78
  • [24] Chronic lung allograft dysfunction
    Masaaki Sato
    Current Respiratory Care Reports, 2014, 3 (3): : 71 - 78
  • [25] Symptomatic Respiratory Virus Infection and Chronic Lung Allograft Dysfunction
    Fisher, Cynthia E.
    Preiksaitis, Carl M.
    Lease, Erika D.
    Edelman, Jeffrey
    Kirby, Katharine A.
    Leisenring, Wendy M.
    Raghu, Ganesh
    Boeckh, Michael
    Limaye, Ajit P.
    CLINICAL INFECTIOUS DISEASES, 2016, 62 (03) : 313 - 319
  • [26] Longitudinal lung function measurements in single lung transplant recipients with chronic lung allograft dysfunction
    Leuschner, Gabriela
    Lauseker, Michael
    Howanietz, Anne-Sophie
    Milger, Katrin
    Veit, Tobias
    Munker, Dieter
    Schneider, Christian
    Weig, Thomas
    Michel, Sebastian
    Barton, Juergen
    Meiser, Bruno
    Dinkel, Julien
    Neurohr, Claus
    Behr, Juergen
    Kneidinger, Nikolaus
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (11) : 1270 - 1278
  • [27] Pharmacotherapy of chronic lung allograft dysfunction post lung transplantation
    Evans, Rickey A.
    Walter, Krysta S.
    Lobo, Leonard Jason
    Coakley, Raymond
    Doligalski, Christina T.
    CLINICAL TRANSPLANTATION, 2022, 36 (08)
  • [28] Comparison of extracorporeal photopheresis and alemtuzumab for the treatment of chronic lung allograft dysfunction
    Moniodis, Anna
    Townsend, Keri
    Rabin, Alexander
    Aloum, Obadah
    Stempel, Jessica
    Burkett, Patrick
    Camp, Phillip
    Divo, Miguel
    El-Chemaly, Souheil
    Mallidi, Hari
    Rosas, Ivan
    Fuhlbrigge, Anne
    Koo, Sophia
    Goldberg, Hilary J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (03) : 340 - 348
  • [29] Chronic Lung Allograft Dysfunction: Evolving Concepts and Therapies
    Amubieya, Olawale
    Ramsey, Allison
    DerHovanessian, Ariss
    Fishbein, Gregory A.
    Lynch, Joseph P., III
    Belperio, John A.
    Weigt, S. Samuel
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 42 (03) : 392 - 410
  • [30] Chronic Lung Allograft Dysfunction: Review of CT and Pathologic Findings
    Byrne, Danielle
    Nador, Roland G.
    English, John C.
    Yee, John
    Levy, Robert
    Bergeron, Celine
    Swiston, John R.
    Mets, Onno M.
    Muller, Nestor L.
    Bilawich, Ana -Maria
    RADIOLOGY-CARDIOTHORACIC IMAGING, 2021, 3 (01):